REED JOHN C (EVP, Innovative Medicine, R&D) sold 83.5% of their position (53.93K shares) of JOHNSON & JOHNSON on the open market
Open‑market sale worth $13.11M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+1.35K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−385.00
Price / share
$243.45
Trade value
$93.73K
% of position
Common Stock
Shares
+1.85K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−528.00
Price / share
$243.45
Trade value
$128.54K
% of position
Common Stock
Shares
+21.72K
Price / share
$157.92
Trade value
$3.43M
% of position
Common Stock
Shares
−21.72K
Price / share
$243.00
Trade value
$5.28M
% of position
Common Stock
Shares
+29.93K
Price / share
$156.15
Trade value
$4.67M
% of position
Common Stock
Shares
−29.93K
Price / share
$243.00
Trade value
$7.27M
% of position
Common Stock
Shares
−2.28K
Price / share
$243.00
Trade value
$554.77K
% of position
Net shares
+0.00
Net value
-$5.22M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/15/2026 | M · Option Exercise | +1.35K | — | — | 12.7% | 10.66K | 12.01K |
| Common Stock Direct | 2/15/2026 | F · Tax Withholding | −385.00 | $243.45 | $93.73K | 3.2% | 12.01K | 11.62K |
| Common Stock Direct | 2/15/2026 | M · Option Exercise | +1.85K | — | — | 15.9% | 11.62K | 13.47K |
| Common Stock Direct | 2/15/2026 | F · Tax Withholding | −528.00 | $243.45 | $128.54K | 3.9% | 13.47K | 12.94K |
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +21.72K | $157.92 | $3.43M | 167.8% | 12.94K | 34.66K |
| Common Stock Direct | 2/17/2026 | S · Sale | −21.72K | $243.00 | $5.28M | 62.7% | 34.66K | 12.94K |
| Common Stock Direct | 2/17/2026 | M · Option Exercise | +29.93K | $156.15 | $4.67M | 231.3% | 12.94K | 42.87K |
| Common Stock Direct | 2/17/2026 | S · Sale | −29.93K | $243.00 | $7.27M | 69.8% | 42.87K | 12.94K |
| Common Stock Direct | 2/17/2026 | S · Sale | −2.28K | $243.00 | $554.77K | 17.6% | 12.94K | 10.66K |
| Total | +0.00 | -$5.22M | ||||||
Restricted Share Units
Common Stock
1.35K shares
Shares
−1.35K
Strike price
Held after
1.35K
Exercisable
—
Restricted Share Units
Common Stock
1.85K shares
Shares
−1.85K
Strike price
Held after
3.69K
Exercisable
—
Employee Stock Options (Right to Buy)
Common Stock
49.38K shares
Shares
+49.38K
Strike price
243.45
Held after
49.38K
Exercisable
—
Restricted Share Units
Common Stock
3.55K shares
Shares
+3.55K
Strike price
Held after
3.55K
Exercisable
—
Employee Stock Options (Right to Buy)
Common Stock
21.72K shares
Shares
−21.72K
Strike price
157.92
Held after
21.72K
Exercisable
—
Employee Stock Options (Right to Buy)
Common Stock
29.93K shares
Shares
−29.93K
Strike price
156.15
Held after
59.85K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Share Units Direct | Common Stock1.35K shares | 2/15/2026 | M · Option Exercise | −1.35K | — | 1.35K | |
| Restricted Share Units Direct | Common Stock1.85K shares | 2/15/2026 | M · Option Exercise | −1.85K | — | 3.69K | |
| Employee Stock Options (Right to Buy) Direct | Common Stock49.38K shares | 2/15/2026 | A · Award | +49.38K | 243.45 | — | 49.38K |
| Restricted Share Units Direct | Common Stock3.55K shares | 2/15/2026 | A · Award | +3.55K | — | 3.55K | |
| Employee Stock Options (Right to Buy) Direct | Common Stock21.72K shares | 2/17/2026 | M · Option Exercise | −21.72K | 157.92 | — | 21.72K |
| Employee Stock Options (Right to Buy) Direct | Common Stock29.93K shares | 2/17/2026 | M · Option Exercise | −29.93K | 156.15 | — | 59.85K |